The first new type of left -hearted ear seal blocker implantation was successfully launched in Wuhan University People's Hospital

Wuhan Evening News, June 27 (Correspondent Yang Cen Confucian) On June 21, Professor Huang He, Director of the Cardiovascular Hospital of Wuhan University People's Hospital (Hubei Provincial People's Hospital) Cardiovascular Hospital, led the team to successfully carry out the latest international left -ear blocking device In the operation, Aunt Zhang, 66, became the first beneficiary of the Central China. Compared with the previous generation, the safety, effectiveness and equipment stability of the left -hearted ear seal blocking are greatly improved, and it will provide a more secure and high -quality treatment experience for 20 million atrial fiber patients in China.

Aunt Zhang is from Huangshi, Hubei. More than 20 years ago, she was diagnosed with persistent atrial fibrillation, hypertotic myocardial disease, heart dysfunction, and type 2 diabetes. Although she took long -term medication for standardized treatment, she often had difficulty in breathing and chest tightness when she worked for housework and climbing stairs. The quality of life was significantly affected.

A week ago, she came to Professor Huang He, Cardiovascular Hospital of the People's Hospital of Wuhan University. After the examination, it is recommended to be hospitalized. Given that Aunt Zhang was evaluated with a very high stroke and bleeding risk (CHA2DS2-VASC scored 5 points, Has-PLED score 3 points), Professor Huang He led the team to comprehensively evaluate, repeatedly studied discussions, and finally decided to implement her left heart block blockage Sope -implanted the latest generation of Watchman FLX ™ left -hearted ear seal blocker.

According to Huang He, the left heart -seal blocking is a minimally invasive surgery. During the operation, a self -expand nickel -titanium alloy umbrella with an inverted device was delivered to the heart from the 3 mm incision of the femoral vein 3 mm of the femoral patient. At the entrance, the left heart and ear heart cavity isolates from the left room. This "parachute" material and human tissue have a high degree of integration, just like building a dam on the left heart, which can reduce the formation of thrombosis and prevent stroke.

In accordance with the surgical plan, in order to accurately position, Professor Huang He led the team to determine the position of the left heart through the esophageal ultrasound and angiography, and accurately released the blocking device to the calibration position. In one hour, the implantation surgery was successfully completed. After the surgery, after the careful treatment of Professor Huang He's team, Aunt Zhang quickly got out of bed. The risk of stroke and bleeding was significantly reduced, and she had troubled her for more than 20 years. She also improved significantly. After two days, he was discharged smoothly.

Yellow Crane led the team to perform surgery for the patient.

According to Huang He, as the process of population aging continues to accelerate, China is facing increasing challenges in comprehensive management of atrial fibrillation and lowering the incidence of stroke. The Cardiovascular Hospital of Wuhan University People's Hospital leads the latest nationwide, the largest sample volume, and the widest regional epidemiological survey by the China Housekeeper Center Union. The result shows that nearly 20 million patients with atrial fibrillation have significantly regional differences, of which the incidence is the highest in the middle and the lowest in the east.

Stroke is the most serious complications of atrial fibrillation, which significantly increases the disability and death rate. The general risk of atrial fiber patients with a stroke is 5 times that of atrial fibrillation patients. The number of strokes caused by atrial fibrillation is about 525,000 per year, accounting for 7.5%of all patients in my country. The cost is as high as RMB 5 billion. The high residual rate caused by the hiking caused by the atrial fibrillation brings a heavy economic burden on the society, patients and their families.

According to Huang He, the left heart ear of the heart is an important part of thrombosis for patients with atrial fibrillation. More than 90%of the blood clotter in non -valve the aquatic atrial fibrillation originated from the left heart ear. For patients with high stroke risks and not suitable for anticoagulant therapy, the left heart block of the heart has proven to be an effective treatment for stroke risks caused by atrial fibrillation.

A new generation of left -hearted ear seal blocker.

It is reported that the "fixed anchor" of the latest generation of left -hearted ear blocking device is upgraded in an all -round way. The safety, effectiveness, and equipment stability of the operation have been greatly improved compared to the previous generation, which greatly reduces the risk of damaging the ear walls of the device. 100%completely blocking rate. In addition, compared with the traditional blocking device, a new generation of blocking device reduces 77%of the metal exposure area, which can promote the endothelialization of the surface of the instrument, reduce the risk of thrombosis on the surface of the device, and allows patients to benefit for a long time.

[Edit: Yu Lina]

- END -